Market Research Logo

Global Fecal Occult Testing market 2016-2020

Global Fecal Occult Testing market 2016-2020

About Fecal Occult Testing

Fecal occult testing is simple and non-invasive in nature, thereby increasing its preference among many physicians. The results of few of the fecal occult tests can be obtained rapidly through point-of-care (POC) test kits such as Alere's Clearview iFOB, and Beckman Coulter's Hemoccult II SENSA. For instance, the Clearview iFOB test is based on human hemoglobin and gastrointestinal bleeding, and can provide results in five minutes. Beckman Coulter's Hemoccult II SENSA slides allow people to collect fecal samples at home settings and send them to hospitals, laboratories, and diagnostic centers.

Technavio’s analysts forecast the global fecal occult testing market to grow at a CAGR of 4.82% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global fecal occult testing market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of fecal occult testing products used to perform colorectal cancer screening.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Fecal Occult Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Beckman Coulter
  • Eiken Chemical
  • Epigenomics
  • Quidel
Other prominent vendors
  • Abbott Laboratories
  • AccuBioTech
  • Applied Proteomics
  • ASAN PHARM.
  • Assure Tech.
  • BIOHIT Healthcare
  • EDP Biotech
  • FUJIREBIO
  • GeneNews
  • NanoRepro
  • Nantong Egens Biotechnology
  • Orion Diagnostica
  • Polymedco
  • Quest Diagnostics
  • Randox
  • VolitionRx
Market driver
  • Government initiatives and pilot programs worldwide
  • For a full, detailed list, view our report
Market challenge
  • High cost of FITs and limited reimbursement
  • For a full, detailed list, view our report
Market trend
  • Direct-to-consumer laboratory testing
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Fecal Occult Testing Market 2016-2020

Technavio recognizes the following companies as the key players in the global fecal occult testing market: Beckman Coulter, Eiken Chemical, Epigenomics, and Quidel.

Other Prominent Vendors in the market are: Abbott Laboratories, AccuBioTech, Applied Proteomics, ASAN PHARM, Assure Tech. (Hangzhou), BIOHIT Healthcare, EDP Biotech, FUJIREBIO, GeneNews, NanoRepro AG, Nantong Egens Biotechnology, Orion Diagnostica, Polymedco, Quest Diagnostics, Randox, and VolitionRx.

Commenting on the report, an analyst from Technavio’s team said: “Direct-to-consumer laboratory testing is an important trend spurring this market’s growth prospects. Direct-to-consumer laboratory testing allows people to receive test kits and send samples to laboratories. Many people in the age group 60 years and above in developed countries such as Australia, the US, the UK, and Germany opt for direct-to-consumer genetic testing. These products can be selected online services and can be accessed from any geographical location. The cost of these products is less compared with traditional genetic testing kits. Direct-to-consumer genetic testing kits cost $100-$1,200. Companies or laboratories such as Color Genomics in the US and Mapmygenome in India offer direct-to-consumer genetic testing services that help identify or screen for colorectal cancer.”

According to the report, shift toward patient-centered model (POC FITs) for home use is one of the ley drivers contributing to the growth of this market. Various government and non-government initiatives have helped increase awareness and research data about colorectal cancer. This presents significant opportunities for improving cancer management. Devices used for testing at or near the site of the patient are known as POC devices. These devices can be used at home settings; however, people need to consult their physicians for further disease diagnosis and treatment. These devices can also be used outside a laboratory and in hospitals and clinics.

Further, the report states that limited awareness and reluctance of physicians to recommend fecal occult testing is a major challenge this market is facing. Awareness about colorectal cancer and associated screening methods among people is limited. Moreover, people who are aware of screening methods mostly opt for colonoscopy; a significant number of physicians worldwide are of the opinion that colonoscopy can help reduce the mortality rate associated with colorectal cancer. The lack of efficacy in test results of fecal occult testing similar to guaiac-based tests and FITs encourages physicians to recommend colonoscopy.

Companies Mentioned

Beckman Coulter, Eiken Chemical, Epigenomics, Quidel, Abbott Laboratories, AccuBioTech, Applied Proteomics, ASAN PHARM, Assure Tech. (Hangzhou), BIOHIT Healthcare, EDP Biotech, FUJIREBIO, GeneNews, NanoRepro AG, Nantong Egens Biotechnology, Orion Diagnostica, Polymedco, Quest Diagnostics, Randox, VolitionRx.

  • Executive summary
    • Highlights
      • Table Global fecal occult testing market: Three significant estimations
  • Scope of the report
    • Market Overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
      • Table Colorectal cancer screening tests: Advantages and disadvantages of fecal occult testing
      • Table Scale of colorectal cancer cases in UK
      • Table Adoption of Cologuard in US 2014-2015\
  • Market landscape
    • Market overview
      • Table Segmentation of global fecal occult testing market
      • Table Global fecal occult testing market: Impact assessment
    • Market size and forecast
      • Table Global fecal occult testing market 2015-2020 ($ millions)
      • Table New cases and deaths related to colorectal cancer per 100,000 people in US 2004-2014
      • Table Government guidelines and support in some developed countries
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product
    • Table Global fecal occult testing market by product 2015 and 2020
    • Global fecal occult testing market by FIT
      • Table Global fecal occult testing market by FIT: An overview
      • Table Global fecal occult testing market by FIT 2015-2020 ($ millions)
      • Table Comparison of FIT and guaiac test
    • Global fecal occult testing market by guaiac test
      • Table Global fecal occult testing market by guaiac test: An overview
      • Table Global fecal occult testing market by guaiac test 2015-2020 ($ millions)
    • Global fecal occult testing market by stool DNA test
      • Table Global fecal occult testing market by stool DNA test: An overview
      • Table Global fecal occult testing market by stool DNA test 2015-2020 ($ millions)
  • Market segmentation by end-user
    • Table Global fecal occult testing market segmentation by end-user 2015
    • Global fecal occult testing market by hospitals
    • Global fecal occult testing market by clinical diagnostic laboratories
      • Table Revenue generated by diagnostic and medical laboratories in US 2009-2014
    • Global fecal occult testing market by physicians' office laboratories
  • Geographical segmentation
    • Table Global fecal occult testing market segmentation by geography 2015 and 2020
    • Fecal occult testing market in Americas
      • Table Fecal occult testing market in Americas: An overview
      • Table Fecal occult testing market in Americas 2015-2020 ($ millions)
      • Table Fecal occult testing market in Americas: Metrics analysis for various countries 2015 and 2020
      • Table Fecal occult testing market in US: Key takeaways
    • Fecal occult testing market in EMEA
      • Table Fecal occult testing market in EMEA: An overview
      • Table Colorectal cancer mortality per 100,000 individuals in European countries 2003 and 2013
      • Table Fecal occult testing market in EMEA 2015-2020 ($ millions)
      • Table Fecal occult testing market in EMEA: Metrics analysis of various countries 2015 and 2020
      • Table Fecal occult testing market in UK: Key takeaways
    • Fecal occult testing market in APAC
      • Table Fecal occult testing market in APAC: An overview
      • Table Colorectal cancer mortality per 100,000 individuals in APAC 2003 and 2013
      • Table Fecal occult testing market in APAC 2015-2020 ($ millions)
      • Table Fecal occult testing market in APAC: Metrics analysis for various countries 2015 and 2020
  • Market drivers
    • Rise in geriatric population
      • Table People in age group 60 years and above worldwide 2010-2050
    • Government initiatives and pilot programs worldwide
      • Table Government initiatives for colorectal cancer and fecal occult testing in some countries
    • Shift toward patient-centered model (POC FITs) for home use
      • Table Some POC FITs available in market
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • High cost of FITs and limited reimbursement
    • Inaccuracies in diagnosis
    • Limited awareness and reluctance of physicians to recommend fecal occult testing
      • Table Study results: Potential barriers affecting adoption of FOBTs
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Collaboration between research centers and manufacturers
      • Table Some collaborations and their impact
    • Online marketing of fecal occult immunological test devices
      • Table Some companies and their distribution partners
    • Direct-to-consumer laboratory testing
  • Vendor landscape
    • Competitive scenario
      • Table Global fecal occult testing market: Competitive structure analysis 2015
      • Table Global fecal occult testing market: Competitive landscape analysis
      • Table Market penetration of vendors of fecal occult testing kits 2015
      • Table Global fecal occult testing market: Strategic success factors of companies
  • Key vendor analysis
    • Geographical presence: Major vendors
      • Table Major vendors: Regional analysis
    • Beckman Coulter
      • Table Beckman Coulter: Profile summary
      • Table Beckman Coulter: Strength analysis
      • Table Beckman Coulter: Growth strategy matrix
      • Table Beckman Coulter: Opportunity assessment
    • Eiken Chemical
      • Table Eiken Chemical: Profile summary
      • Table Eiken Chemical: Strength analysis
      • Table Eiken Chemical: Growth strategy matrix
      • Table Eiken Chemical: Opportunity assessment
    • Epigenomics
      • Table Epigenomics: Profile summary
      • Table Epigenomics: Strength analysis
      • Table Epigenomics: Growth strategy matrix
      • Table Epigenomics: Opportunity assessment
    • Quidel
      • Table Quidel: Profile summary
      • Table Quidel: Strength analysis
      • Table Quidel: Growth strategy matrix
      • Table Quidel: Opportunity assessment
    • Key news
    • Other prominent vendors
      • Table Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report